mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |